Backes Y, de Vos Tot Nederveen Cappel W H, van Bergeijk J, Ter Borg F, Schwartz M P, Spanier B W M, Geesing J M J, Kessels K, Kerkhof M, Groen J N, Wolfhagen F H J, Seerden T C J, van Lelyveld N, Offerhaus G J A, Siersema P D, Lacle M M, Moons L M G
Department of Gastroenterology and Hepatology, University Medical Centre Utrecht, Utrecht, The Netherlands.
Department of Gastroenterology and Hepatology, Isala, Zwolle, The Netherlands.
Am J Gastroenterol. 2017 May;112(5):785-796. doi: 10.1038/ajg.2017.58. Epub 2017 Mar 21.
The decision to perform secondary surgery after endoscopic resection of T1 colorectal cancer (CRC) depends on the risk of lymph node metastasis and the risk of incomplete resection. We aimed to examine the incidence and risk factors for incomplete endoscopic resection of T1 CRC after a macroscopic radical endoscopic resection.
Data from patients treated between 2000 and 2014 with macroscopic complete endoscopic resection of T1 CRC were collected from 13 hospitals. Incomplete resection was defined as local recurrence at the polypectomy site during follow-up or malignant tissue in the surgically resected specimen in case secondary surgery was performed. Multivariate regression analysis was performed to analyze factors associated with incomplete resection.
In total, 877 patients with a median follow-up time of 36.5 months (interquartile range 16.0-68.3) were included, in whom secondary surgery was performed in 358 patients (40.8%). Incomplete resection was observed in 30 patients (3.4%; 95% confidence interval (CI) 2.3-4.6%). Incomplete resection rate was 0.7% (95% CI 0-2.1%) in low-risk T1 CRC vs. 4.4% (95% CI 2.7-6.5%) in high-risk T1 CRC (P=0.04). Overall adverse outcome rate (incomplete resection or metastasis) was 2.1% (95% CI 0-5.0%) in low-risk T1 CRC vs. 11.7% (95% CI 8.8-14.6%) in high-risk T1 CRC (P=0.001). Piecemeal resection (adjusted odds ratio 2.60; 95% CI 1.20-5.61, P=0.02) and non-pedunculated morphology (adjusted odds ratio 2.18; 95% CI 1.01-4.70, P=0.05) were independent risk factors for incomplete resection. Among patients in whom no additional surgery was performed, who developed recurrent cancer, 41.7% (95% CI 20.8-62.5%) died as a result of recurrent cancer.
In the absence of histological high-risk factors, a 'wait-and-see' policy with limited follow-up is justified. Piecemeal resection and non-pedunculated morphology are independent risk factors for incomplete endoscopic resection of T1 CRC.
T1期结直肠癌(CRC)内镜切除术后是否进行二次手术的决策取决于淋巴结转移风险和切除不完全的风险。我们旨在研究宏观根治性内镜切除术后T1期CRC内镜切除不完全的发生率及危险因素。
收集了2000年至2014年间13家医院对T1期CRC进行宏观完全内镜切除的患者数据。切除不完全定义为随访期间息肉切除部位局部复发,或进行二次手术时手术切除标本中有恶性组织。进行多因素回归分析以分析与切除不完全相关的因素。
共纳入877例患者,中位随访时间为36.5个月(四分位间距16.0 - 68.3),其中358例患者(40.8%)接受了二次手术。30例患者(3.4%;95%置信区间(CI)2.3 - 4.6%)出现切除不完全。低风险T1期CRC的切除不完全率为0.7%(95% CI 0 - 2.1%),而高风险T1期CRC为4.4%(95% CI 2.7 - 6.5%)(P = 0.04)。低风险T1期CRC的总体不良结局率(切除不完全或转移)为2.1%(95% CI 0 - 5.0%),高风险T1期CRC为11.7%(95% CI 8.8 - 14.6%)(P = 0.001)。分块切除(调整比值比2.60;95% CI 1.20 - 5.61,P = 0.02)和无蒂形态(调整比值比2.18;95% CI 1.01 - 4.70,P = 0.05)是切除不完全的独立危险因素。在未进行额外手术且发生复发性癌症的患者中,41.7%(95% CI 20.8 - 62.5%)因复发性癌症死亡。
在没有组织学高危因素的情况下,采用有限随访的“观察等待”策略是合理的。分块切除和无蒂形态是T1期CRC内镜切除不完全的独立危险因素。